1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Preece, N.E.
Nguyen, M.
Mahata, M.
Mahata, S.K.
Mahapatra, N.R.
Tsigelny, I.
O'Connor, D.T.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
NE
Regul.Pept.
0167-0115
118
75
87
10.1016/j.regpep.2003.10.035
14759560
Conformational preferences and activities of peptides from the catecholamine
release-inhibitory (catestatin) region of chromogranin A
2004
10.2210/pdb1n2y/pdb
pdb_00001n2y
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
1
1.0
1662.961
CATESTATIN
1
syn
polymer
no
no
CFRARGYGFRGPGLC
CFRARGYGFRGPGLC
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
database_2
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2002-11-13
1
1
2008-04-28
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
2002-11-13
SPRSDE
SEQUENCE
THE TERMINAL CYSTEINES ARE NON-NATIVE BUT WERE
INCLUDED TO FACILITATE THE SYNTHESIS OF THE
CYCLIC PEPTIDE.
RCSB
Y
RCSB
2002-10-24
REL
REL
THIS PEPTIDE WAS CHEMICALLY SYNTHESIZED. SOLID PHASE SYNTHESIS AND FACILE CYCLIZATION OF TERMINAL CYSTEINES BY OXIDATION WAS PERFORMED. THE SEQUENCE OF THE PEPTIDE IS NATURALLY FOUND IN BOS TAURUS (COW).
sample
DMSO-D6
DOMINANT CLUSTER and outliers
20
12
2D NOESY
DQF-COSY
P-COSY
BASHD-TOCSY
10 mM PHOSPHATE
7
AMBIENT
278
K
RESTRAINED MOLECULAR DYNAMICS, CHEMICAL SHIFT REFINEMENT
8
4MG SS-CYCLIZED CATESTATIN 15-MER
refinement
X-PLOR
structure solution
VNMR
structure solution
Felix
structure solution
Discover
structure solution
X-PLOR
500
Varian
UNITYPLUS
500
Varian
INOVA
CYS
1
n
1
CYS
1
A
PHE
2
n
2
PHE
2
A
ARG
3
n
3
ARG
3
A
ALA
4
n
4
ALA
4
A
ARG
5
n
5
ARG
5
A
GLY
6
n
6
GLY
6
A
TYR
7
n
7
TYR
7
A
GLY
8
n
8
GLY
8
A
PHE
9
n
9
PHE
9
A
ARG
10
n
10
ARG
10
A
GLY
11
n
11
GLY
11
A
PRO
12
n
12
PRO
12
A
GLY
13
n
13
GLY
13
A
LEU
14
n
14
LEU
14
A
CYS
15
n
15
CYS
15
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
A
N
HA3
CYS
GLY
1
11
1.24
1
A
A
H
HA3
CYS
GLY
1
11
1.33
1
A
A
H
O
PHE
ARG
2
10
1.36
1
A
A
N
CA
CYS
GLY
1
11
2.15
2
A
A
H
H
ARG
GLY
5
6
0.99
2
A
A
O
H
ARG
GLY
3
13
1.57
3
A
A
O
HD2
PHE
PRO
9
12
1.55
3
A
A
O
N
PHE
GLY
9
11
2.14
4
A
A
O
N
ARG
ARG
3
5
1.81
4
A
A
O
N
PHE
GLY
9
11
2.15
5
A
A
O
O
ALA
GLY
4
8
1.82
6
A
A
H
O
CYS
LEU
1
14
1.50
6
A
A
O
O
ALA
LEU
4
14
2.00
7
A
A
H
H
ARG
GLY
5
6
1.07
7
A
A
O
H
GLY
ARG
8
10
1.13
7
A
A
O
H
ARG
GLY
3
13
1.34
7
A
A
O
N
GLY
ARG
8
10
1.84
7
A
A
O
N
ARG
GLY
3
13
2.15
8
A
A
O
N
ARG
ARG
3
5
1.90
10
A
A
H
O
CYS
ARG
1
3
1.59
10
A
A
O
C
ALA
PHE
4
9
2.18
12
A
A
O
HA
CYS
LEU
1
14
1.51
12
A
A
O
O
ARG
ARG
3
10
1.71
1
A
ARG
3
0.304
SIDE CHAIN
1
A
ARG
5
0.280
SIDE CHAIN
1
A
ARG
10
0.263
SIDE CHAIN
2
A
ARG
3
0.206
SIDE CHAIN
2
A
ARG
5
0.296
SIDE CHAIN
2
A
ARG
10
0.311
SIDE CHAIN
3
A
ARG
3
0.308
SIDE CHAIN
3
A
ARG
5
0.316
SIDE CHAIN
3
A
ARG
10
0.313
SIDE CHAIN
4
A
ARG
3
0.189
SIDE CHAIN
4
A
ARG
5
0.285
SIDE CHAIN
4
A
ARG
10
0.302
SIDE CHAIN
5
A
ARG
3
0.298
SIDE CHAIN
5
A
ARG
5
0.247
SIDE CHAIN
5
A
ARG
10
0.267
SIDE CHAIN
6
A
ARG
3
0.148
SIDE CHAIN
6
A
ARG
5
0.315
SIDE CHAIN
6
A
ARG
10
0.249
SIDE CHAIN
7
A
ARG
3
0.293
SIDE CHAIN
7
A
ARG
5
0.266
SIDE CHAIN
7
A
ARG
10
0.268
SIDE CHAIN
8
A
ARG
3
0.327
SIDE CHAIN
8
A
ARG
5
0.312
SIDE CHAIN
8
A
ARG
10
0.224
SIDE CHAIN
9
A
ARG
3
0.310
SIDE CHAIN
9
A
ARG
5
0.229
SIDE CHAIN
9
A
ARG
10
0.316
SIDE CHAIN
10
A
ARG
3
0.311
SIDE CHAIN
10
A
ARG
5
0.318
SIDE CHAIN
10
A
ARG
10
0.306
SIDE CHAIN
11
A
ARG
3
0.316
SIDE CHAIN
11
A
ARG
5
0.223
SIDE CHAIN
11
A
ARG
10
0.310
SIDE CHAIN
12
A
ARG
3
0.289
SIDE CHAIN
12
A
ARG
5
0.245
SIDE CHAIN
12
A
ARG
10
0.306
SIDE CHAIN
1
-18.87
2.50
113.10
94.23
A
A
A
N
CA
C
GLY
GLY
GLY
6
6
6
N
2
-16.66
2.50
113.10
96.44
A
A
A
N
CA
C
GLY
GLY
GLY
6
6
6
N
2
9.44
1.50
119.30
128.74
A
A
A
C
N
CA
GLY
PRO
PRO
11
12
12
Y
2
-31.78
2.10
128.40
96.62
A
A
A
C
N
CD
GLY
PRO
PRO
11
12
12
Y
3
-18.18
2.50
113.10
94.92
A
A
A
N
CA
C
GLY
GLY
GLY
6
6
6
N
3
-16.09
2.50
113.10
97.01
A
A
A
N
CA
C
GLY
GLY
GLY
8
8
8
N
4
-16.86
2.70
111.00
94.14
A
A
A
N
CA
C
ARG
ARG
ARG
3
3
3
N
6
-19.30
2.70
111.00
91.70
A
A
A
N
CA
C
ARG
ARG
ARG
3
3
3
N
6
-21.63
2.10
128.40
106.77
A
A
A
C
N
CD
GLY
PRO
PRO
11
12
12
Y
7
-11.73
1.90
113.40
101.67
A
A
A
CA
CB
CG
TYR
TYR
TYR
7
7
7
N
7
-16.99
2.50
113.10
96.11
A
A
A
N
CA
C
GLY
GLY
GLY
8
8
8
N
8
-18.10
2.70
111.00
92.90
A
A
A
N
CA
C
ARG
ARG
ARG
3
3
3
N
8
-11.28
1.80
110.60
99.32
A
A
A
N
CA
CB
ARG
ARG
ARG
5
5
5
N
9
-13.39
1.80
110.60
97.21
A
A
A
N
CA
CB
ARG
ARG
ARG
10
10
10
N
9
-27.52
2.10
128.40
100.88
A
A
A
C
N
CD
GLY
PRO
PRO
11
12
12
Y
10
-18.42
2.70
111.00
92.58
A
A
A
N
CA
C
ARG
ARG
ARG
3
3
3
N
10
-19.67
2.70
111.00
91.33
A
A
A
N
CA
C
ALA
ALA
ALA
4
4
4
N
10
-18.96
2.50
113.10
94.14
A
A
A
N
CA
C
GLY
GLY
GLY
8
8
8
N
11
-15.11
2.50
113.10
97.99
A
A
A
N
CA
C
GLY
GLY
GLY
13
13
13
N
12
-10.91
1.40
110.10
99.19
A
A
A
N
CA
CB
ALA
ALA
ALA
4
4
4
N
12
-19.14
2.50
113.10
93.96
A
A
A
N
CA
C
GLY
GLY
GLY
6
6
6
N
12
-12.65
2.00
116.20
103.55
A
A
A
CA
C
N
TYR
TYR
GLY
7
7
8
Y
12
-16.05
2.50
113.10
97.05
A
A
A
N
CA
C
GLY
GLY
GLY
8
8
8
N
12
-10.74
1.40
111.70
100.96
A
A
A
CA
N
CD
PRO
PRO
PRO
12
12
12
N
1
A
PHE
2
-127.46
-86.92
1
A
TYR
7
-38.93
154.13
1
A
PRO
12
35.96
-76.12
2
A
ARG
3
-105.40
-67.89
2
A
ARG
5
-162.84
-22.66
2
A
ARG
10
-42.91
177.52
2
A
PRO
12
-27.27
173.68
3
A
ARG
3
-122.14
-68.09
3
A
TYR
7
-44.24
87.09
3
A
ARG
10
-28.95
85.23
3
A
PRO
12
-41.43
-81.20
3
A
LEU
14
-109.24
75.88
4
A
PHE
2
-95.00
-67.56
4
A
ALA
4
-23.23
71.94
4
A
ARG
10
-41.93
81.58
4
A
PRO
12
-76.18
-111.60
4
A
LEU
14
-121.10
-73.33
5
A
PHE
2
-126.18
-69.67
5
A
ARG
3
-121.62
-63.19
5
A
ARG
5
-81.96
44.00
5
A
TYR
7
-124.36
-59.91
5
A
PHE
9
-37.26
-32.08
5
A
PRO
12
-60.53
-140.32
5
A
LEU
14
-116.03
-124.57
6
A
PHE
2
-81.47
-77.05
6
A
ARG
3
-69.10
-104.95
6
A
ARG
5
-169.57
-44.91
6
A
TYR
7
-119.71
-70.90
6
A
PHE
9
-19.51
70.37
6
A
ARG
10
-131.96
-116.15
6
A
PRO
12
51.04
-108.70
6
A
LEU
14
-54.55
-166.93
7
A
ARG
3
-106.17
-75.61
7
A
ARG
5
-161.19
-9.54
7
A
PHE
9
-23.85
42.76
7
A
PRO
12
37.38
-87.62
7
A
LEU
14
-99.92
59.11
8
A
PHE
2
-128.42
-66.65
8
A
ALA
4
-16.80
71.91
8
A
ARG
10
-43.01
82.28
8
A
PRO
12
-65.18
-138.82
8
A
LEU
14
-116.49
-152.42
9
A
PHE
2
-124.58
-83.41
9
A
ARG
3
-107.62
-74.88
9
A
ALA
4
-142.40
38.72
9
A
ARG
5
-152.69
5.11
9
A
ARG
10
-38.92
-179.33
9
A
PRO
12
-90.59
-74.26
10
A
PHE
2
-65.88
-77.72
10
A
ARG
3
-84.10
-79.86
10
A
ALA
4
-145.99
59.46
10
A
ARG
5
-145.90
25.90
10
A
TYR
7
-121.32
-129.55
10
A
PHE
9
-36.94
-75.40
10
A
PRO
12
-46.89
-104.03
11
A
PHE
2
-94.07
-102.95
11
A
ARG
3
-74.21
-73.77
11
A
ARG
5
-83.46
40.13
11
A
PHE
9
-116.06
78.95
11
A
ARG
10
-43.95
99.75
11
A
PRO
12
-9.42
-51.56
11
A
LEU
14
-53.30
-163.73
12
A
PHE
2
-39.26
-142.82
12
A
TYR
7
-56.95
179.87
12
A
PHE
9
-141.51
43.20
12
A
ARG
10
-69.55
54.31
12
A
PRO
12
-16.79
-70.50
SOLUTION STRUCTURE OF SS-CYCLIZED CATESTATIN FRAGMENT FROM CHROMOGRANIN A
1
N
N
disulf
2.035
A
CYS
1
A
SG
CYS
1
1_555
A
CYS
15
A
SG
CYS
15
1_555
SIGNALING PROTEIN
CATESTATIN CHOROMOGRANIN A, SIGNALING PROTEIN
CMGA_BOVIN
UNP
1
368
P05059
FRARGYGFRGPGL
368
380
1N2Y
2
14
P05059
A
1
2
14
1
SEE REMARK 999
CYS
1
1N2Y
A
P05059
UNP
1
1
SEE REMARK 999
CYS
15
1N2Y
A
P05059
UNP
15
1
P 1